{
  "hash": "14f20a94dd4405ad50355d2f562cf3f9",
  "result": {
    "engine": "knitr",
    "markdown": "---\ntitle: \"Intervention impact\"\ndate: \"2025-10-07\"     # ISO format; quoted\ndate-format: \"D MMMM YYYY\"  # optional: 25 September 2025\nformat: \n  html:\n    code-fold: true\n    number-sections: false\nexecute:\n  echo: false\n  warning: false\n  freeze: true         # (you can keep this on after you refresh the cache)\nbibliography: references.bib\ncsl: nature.csl\n---\n\n## Score trajectory\n\n\n::: {.cell}\n\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nSCORE TRAJECTORY ANALYSIS - PROSPECTIVE ONLY\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nSimplified Approach\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nTotal records loaded: 3170 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Identifying Data Structure ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nFound filter column: filter_$\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nUsing filter column: filter_$ \nFilter column distribution:\n\n   0    1 \n2478  692 \n\n=== Extracting Prospective Data ===\nProspective baseline records: 171 \nUnique prospective patients: 171 \n\nProspective score records: 1067 \nUnique patients with scores: 169 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Processing Baseline Data ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nBaseline processing complete\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nOutcome distribution:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n     Censored CRE Infection         Death     Discharge \n            5            54            14            98 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Processing Score Data ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nValid score records: 655 \n\n=== Joining Data ===\nFinal longitudinal records: 649 \nUnique patients: 158 \n\n=== Trajectory Analysis ===\n\nPatient trajectory summary:\n  Patients analyzed: 158 \n  Mean scores per patient: 4.11 \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![](intervention_files/figure-html/unnamed-chunk-3-1.png){width=672}\n:::\n:::\n\n\nIndividual patient score trajectories (gray lines) and locally weighted regression curves (LOESS, red line with 95% confidence interval in gray shading) are shown for the first 75 days post-transplant, stratified by primary clinical outcome. The risk score incorporates clinical and laboratory parameters to quantify CRE infection risk. Censored patients (n=X) had incomplete follow-up without reaching a definitive endpoint. CRE infection (n=X) includes all patients who developed carbapenem-resistant Enterobacteriaceae infections during follow-up. Death (n=X) represents all-cause mortality. Discharge (n=X) indicates successful hospital discharge without CRE infection or death. Score trajectories demonstrate distinct patterns: discharged patients show early peak and resolution, deaths show progressive elevation, CRE infections display high variability, and censored patients maintain persistently elevated scores.\n\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![Maximum Score Distribution by CRE Infection Status](intervention_files/figure-html/fig-score-distribution-boxplot-1.png){#fig-score-distribution-boxplot width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rate by Score Category](intervention_files/figure-html/fig-infection-rate-by-score-1.png){#fig-infection-rate-by-score width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![Relationship Between Maximum Score and CRE Infection Risk](intervention_files/figure-html/fig-continuous-relationship-1.png){#fig-continuous-relationship width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![Score Distribution Density by CRE Infection Status](intervention_files/figure-html/fig-density-comparison-1.png){#fig-density-comparison width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rate by Score Trajectory Pattern](intervention_files/figure-html/fig-trajectory-pattern-1.png){#fig-trajectory-pattern width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Statistical Analysis ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nT-test for maximum score difference:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Mean score (No CRE): 17.11 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Mean score (CRE): 31.34 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Difference: 14.22 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  p-value: 2.0183e-05 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nWilcoxon rank-sum test:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  p-value: 5.6508e-06 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nLogistic Regression Results:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nCall:\nglm(formula = cre_infection ~ max_score, family = binomial(), \n    data = score_cre_analysis)\n\nCoefficients:\n            Estimate Std. Error z value Pr(>|z|)    \n(Intercept) -1.89910    0.32374  -5.866 4.46e-09 ***\nmax_score    0.04854    0.01110   4.371 1.23e-05 ***\n---\nSignif. codes:  0 '***' 0.001 '**' 0.01 '*' 0.05 '.' 0.1 ' ' 1\n\n(Dispersion parameter for binomial family taken to be 1)\n\n    Null deviance: 197.24  on 157  degrees of freedom\nResidual deviance: 174.60  on 156  degrees of freedom\nAIC: 178.6\n\nNumber of Fisher Scoring iterations: 4\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nOdds Ratio per unit increase in max score: 1.05 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n95% CI: 1.028 - 1.074 \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\nScore Summary by CRE Status:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 2 × 8\n  cre_status         n baseline_mean baseline_sd max_mean max_sd trajectory_mean\n  <fct>          <int>         <dbl>       <dbl>    <dbl>  <dbl>           <dbl>\n1 No CRE Infect…   108          7.64        11.6     17.1   14.1             6.7\n2 CRE Infection     50         12.1         12.7     31.3   19.9            16.5\n# ℹ 1 more variable: trajectory_sd <dbl>\n```\n\n\n:::\n:::\n\n\n## SCORE-driven CRE treatment\n\n\n::: {.cell}\n\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nANTI-CRE THERAPY EFFECTIVENESS ANALYSIS\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nBased on score_impact___2 (Therapy Started)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Understanding the Variables ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___1 = No action taken\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___2 = Anti-CRE therapy started (OUR FOCUS)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___3 = Diagnostic test performed\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Processing Score Impact Data ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nScore assessments processed: 655 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments where therapy started: 43 ( 6.6 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments with no action: 572 ( 87.3 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments with diagnostic test: 42 ( 6.4 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Creating Patient-Level Summary ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nPatient-level summary:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nTotal patients analyzed: 158 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nPatients who received score-based therapy: 36 ( 22.8 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nCRE infections overall: 50 ( 31.6 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Overall Treatment Effect (score_impact___2) ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 2 × 9\n  received_score_based_therapy     n n_infections infection_rate mean_max_score\n                         <dbl> <int>        <int>          <dbl>          <dbl>\n1                            0   122           28          0.230           16.6\n2                            1    36           22          0.611           38.8\n# ℹ 4 more variables: sd_score <dbl>, therapy_label <chr>, ci_lower <dbl>,\n#   ci_upper <dbl>\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nStatistical Tests:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Fisher's exact test p-value: 3.2718e-05 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Odds ratio: 5.209 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Treatment Effectiveness Metrics ===\nInfection rate WITHOUT score-based therapy: 23 %\nInfection rate WITH score-based therapy: 61.1 %\nAbsolute Risk Reduction (ARR): -38.16 %\nRelative Risk Reduction (RRR): -166.27 %\n\n✗ Score-based therapy appears HARMFUL (paradox - likely confounding)\n  Note: High-risk patients more likely to receive therapy\n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rates by Score-Based Therapy Status](intervention_files/figure-html/fig-therapy-overall-1.png){#fig-therapy-overall width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Stratified Analysis by Risk Score ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nRisk-Stratified Results:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 3 × 7\n  risk_group          n_therapy_0 n_therapy_1 infection_rate_therapy_0\n  <chr>                     <int>       <int>                    <dbl>\n1 High Risk (>20)              36          28                    0.361\n2 Low Risk (≤10)               44           4                    0.114\n3 Medium Risk (11-20)          42           4                    0.238\n# ℹ 3 more variables: infection_rate_therapy_1 <dbl>, arr <dbl>, nnt <lgl>\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Within-Stratum Statistical Tests ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n Low Risk (≤10) :\n  p-value: 0.011872 \n  Odds ratio: 20.735 \n\n Medium Risk (11-20) :\n  p-value: 0.27577 \n  Odds ratio: 3.104 \n\n High Risk (>20) :\n  p-value: 0.076925 \n  Odds ratio: 2.69 \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rates Stratified by Risk Score](intervention_files/figure-html/fig-therapy-stratified-1.png){#fig-therapy-stratified width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Probability by Maximum Score](intervention_files/figure-html/fig-therapy-continuous-1.png){#fig-therapy-continuous width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![Score-Based Therapy Utilization and Infection Rates](intervention_files/figure-html/fig-therapy-utilization-1.png){#fig-therapy-utilization width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Regression Analysis Adjusting for Baseline Risk ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nUnadjusted Analysis:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Therapy coefficient: 1.663 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Therapy OR: 5.276 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nAdjusted for Risk Score:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Therapy coefficient: 0.965 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Therapy OR: 2.625 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Score coefficient: 0.037 \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nTHERAPY EFFECTIVENESS SUMMARY\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n1. KEY FINDING:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n   ✗ Paradox detected: Therapy group has HIGHER infection rate\n   - Likely due to confounding by indication\n   - High-risk patients → Get therapy AND get infected\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n2. CLINICAL INTERPRETATION:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n   - Score successfully identifies high-risk patients\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n   - These patients appropriately receive therapy\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n   - True effectiveness requires risk adjustment or RCT\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n3. RECOMMENDATIONS:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n   - Review therapy effectiveness\n   - Consider alternative interventions\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAnalysis Complete\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n:::\n\n\n## SCORE-driven diagnostic testing\n\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nDIAGNOSTIC TEST UTILIZATION ANALYSIS\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nBased on score_impact___3 (Diagnostic Test Performed)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n============================================\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Understanding the Variables ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___1 = No action taken\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___2 = Anti-CRE therapy started\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nscore_impact___3 = Diagnostic test performed (OUR FOCUS)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Processing Score Impact Data for Diagnostics ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nScore assessments processed: 655 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments with diagnostic test: 42 ( 6.4 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments with therapy: 43 ( 6.6 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAssessments with no action: 572 ( 87.3 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Creating Patient-Level Summary for Diagnostic Tests ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nPatient-level summary:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nTotal patients analyzed: 158 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nPatients who had score-based diagnostic test: 31 ( 19.6 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nCRE infections overall: 50 ( 31.6 %)\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Overall Diagnostic Test Effect (score_impact___3) ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 2 × 9\n  had_score_based_diagnostic     n n_infections infection_rate mean_max_score\n                       <dbl> <int>        <int>          <dbl>          <dbl>\n1                          0   127           30          0.236           19.2\n2                          1    31           20          0.645           31.8\n# ℹ 4 more variables: sd_score <dbl>, diagnostic_label <chr>, ci_lower <dbl>,\n#   ci_upper <dbl>\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nStatistical Tests:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Fisher's exact test p-value: 2.7221e-05 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Odds ratio: 5.799 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Diagnostic Test Impact Metrics ===\nInfection rate WITHOUT diagnostic test: 23.6 %\nInfection rate WITH diagnostic test: 64.5 %\nAbsolute Risk Difference: -40.89 %\nRelative Risk Reduction: -173.12 %\n\n✗ Diagnostic testing associated with HIGHER infection rates\n  Note: Likely confounding - sicker patients get more testing\n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rates by Diagnostic Test Utilization](intervention_files/figure-html/fig-diagnostic-overall-1.png){#fig-diagnostic-overall width=768}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Stratified Analysis by Risk Score ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nRisk-Stratified Diagnostic Test Results:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 3 × 7\n  risk_group       n_diag_0 n_diag_1 infection_rate_diag_0 infection_rate_diag_1\n  <chr>               <int>    <int>                 <dbl>                 <dbl>\n1 High Risk (>20)        42       22                 0.429                 0.545\n2 Low Risk (≤10)         45        3                 0.133                 0.667\n3 Medium Risk (11…       40        6                 0.15                  1    \n# ℹ 2 more variables: arr <dbl>, nnt <lgl>\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Within-Stratum Statistical Tests ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\n Low Risk (≤10) :\n  p-value: 0.067993 \n  Odds ratio: 11.88 \n\n Medium Risk (11-20) :\n  p-value: 9.8646e-05 \n  Odds ratio: Inf \n\n High Risk (>20) :\n  p-value: 0.43519 \n  Odds ratio: 1.588 \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Rates Stratified by Risk Score and Diagnostic Testing](intervention_files/figure-html/fig-diagnostic-stratified-1.png){#fig-diagnostic-stratified width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![CRE Infection Probability by Maximum Score and Diagnostic Testing](intervention_files/figure-html/fig-diagnostic-continuous-1.png){#fig-diagnostic-continuous width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n![Diagnostic Test Utilization and Infection Rates by Score Category](intervention_files/figure-html/fig-diagnostic-utilization-1.png){#fig-diagnostic-utilization width=960}\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Interaction Between Diagnostic Tests and Therapy ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n\nIntervention Combinations:\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 4 × 5\n  intervention_group     n n_infections infection_rate mean_score\n  <chr>              <int>        <int>          <dbl>      <dbl>\n1 Both                  13            7          0.538       43.5\n2 Diagnostic Only       18           13          0.722       23.3\n3 Neither              104           15          0.144       15.4\n4 Therapy Only          23           15          0.652       36.1\n```\n\n\n:::\n:::\n\n\n::: callout-note\nThe scoring system is working to identify risk, but we cannot determine therapy effectiveness from these observational data due to confounding by indication that persists. I could try more propensity score matching but I am not convinced this will resolved the issue. It is surprising:\n\n-   Only 6.6% of patients had therapy changes with the score\n\n-   Only 6.4% had diagnostic changes with the score\n:::\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n=== ROC Analysis Results ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAUC for max score: 0.725 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n95% CI: 0.639 - 0.81 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nOptimal cutpoint (Youden method):\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Score threshold: 23.8 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Sensitivity: 60 %\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n  Specificity: 80.6 %\n```\n\n\n:::\n\n::: {.cell-output-display}\n![](intervention_files/figure-html/discrimination-analysis-fixed-1.png){width=768}\n:::\n:::\n\n\n\n::: {.cell}\n\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 4 × 4\n  primary_outcome     n avg_velocity avg_max_velocity\n  <chr>           <int>        <dbl>            <dbl>\n1 CRE Infection      44      Inf               Inf   \n2 Censored            2        0.606             1.25\n3 Death              11        2.87              5.53\n4 Discharge          81      Inf               Inf   \n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 4 × 5\n  risk_category     n n_cre cre_rate mortality_rate\n  <fct>         <int> <int>    <dbl>          <dbl>\n1 Low              48     8    0.167         0.0208\n2 Moderate         47    12    0.255         0.0851\n3 High             20     5    0.25          0.1   \n4 Very High        43    25    0.581         0.163 \n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\n# A tibble: 4 × 7\n  risk_category     n n_cre cre_rate mortality_rate   nnt recommendation        \n  <fct>         <int> <int>    <dbl>          <dbl> <dbl> <chr>                 \n1 Low              48     8    0.167         0.0208     6 Standard monitoring   \n2 Moderate         47    12    0.255         0.0851     4 Enhanced surveillance \n3 High             20     5    0.25          0.1        4 Consider prophylaxis  \n4 Very High        43    25    0.581         0.163      2 Aggressive interventi…\n```\n\n\n:::\n:::\n\n\n\n::: {.cell}\n::: {.cell-output .cell-output-stdout}\n\n```\n\n=== Bootstrap Validation Results (n= 100 ) ===\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nAUC:  0.721  (95% CI:  0.647 - 0.78 )\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nOptimal cutpoint:  23.2  (95% CI:  14.4 - 25.4 )\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nSensitivity:  0.621  (95% CI:  0.478 - 0.818 )\n```\n\n\n:::\n\n::: {.cell-output .cell-output-stdout}\n\n```\nSpecificity:  0.792  (95% CI:  0.548 - 0.88 )\n```\n\n\n:::\n:::\n\n",
    "supporting": [
      "intervention_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}